Abstract

Myelination is a fundamental biological process in the vertebrate nervous system. Direct detection and quantification of myelin content in vivo can facilitate diagnosis and therapeutic treatment of myelin-related diseases such as multiple sclerosis. Over the past decade, a series of myelin-specific molecule probes with stilbene structural frame have been developed. Herein, a class of novel Nile Red analogs containing the structure feature similar to stilbene have been designed and synthesized. Their structures were confirmed by 1H NMR, 13C NMR, and HRMS analyses. All of them fluoresce in the near-infrared range with emission wavelengths ranging from 651 nm to 691 nm. In vitro assays revealed that these compounds can specifically bind to myelinated fibers and 9-diethylamino-1-methylamino-5H-benzo[a]phenoxazin-5-one (20, 1-MeNHNR) was screened as lead compound. Ex vivo imaging and in vivo near-infrared fluorescence (NIRF) imaging demonstrated that 1-MeNHNR is a promising NIRF probe for myelin imaging.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.